Metraipolis › archive › dc_1f53fc2ea5d6

Chrono-immunotherapy's current and future optimization strategies: immunotherapy timing in line with the circadian rhythm brings longer survival benefits — Europe PMC PMID:41777887

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41777887
DOI
10.3389/fimmu.2026.1777437
License (as archived)
solo-consultazione
Archived
2026-11-05T18:01:25.074Z
SHA-256 of the archived text
2b05e0d4046e77c56302c140db19ef380e104ff6c000ebd670fc02b45204b8f7
Stable URL of this page
https://metraipolis.com/documento/dc_1f53fc2ea5d6

How to cite

Chrono-immunotherapy's current and future optimization strategies: immunotherapy timing in line with the circadian rhythm brings longer survival benefits — Europe PMC PMID:41777887 — Europe PMC (en), https://europepmc.org/article/MED/41777887 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1f53fc2ea5d6 (Metraipolis archive dc_1f53fc2ea5d6, sha256 2b05e0d4046e77c56302c140db19ef380e104ff6c000ebd670fc02b45204b8f7)
BibTeX
@misc{dc1f53fc2ea5d6,
  title = {Chrono-immunotherapy's current and future optimization strategies: immunotherapy timing in line with the circadian rhythm brings longer survival benefits — Europe PMC PMID:41777887},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41777887},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1f53fc2ea5d6; sha256 2b05e0d4046e77c56302c140db19ef380e104ff6c000ebd670fc02b45204b8f7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41777887. Agents can read the archived copy with the MCP tool read_document.